Women in Health Economics and Outcomes Research Initiative Held Session at ISPOR 2018

Published May 21, 2018

Session Featured Special Guest Speaker Laurie Cooke, Healthcare Businesswomen’s Association CEO

Baltimore, MD, USA—May 21, 2018—ISPOR, the professional society for health economics and outcomes research, held a session for its new Women in Health Economics and Outcomes Research (HEOR) initiative this afternoon at ISPOR 2018 in Baltimore, MD, USA. ISPOR launched this initiative in 2017 with the vision to support the growth, development, and contribution of women in HEOR, to serve as a catalyst for women’s leadership in the field, and to offer a platform for ISPOR women to collaborate, network, share, and mentor each other. Laurie Cooke, CEO of the Healthcare Businesswomen’s Association (HBA), was the special guest speaker. Ms Cooke led a panel discussion focused on the advancement of women in the sciences. The panel included: Shelby D. Reed, PhD, RPh, ISPOR President (2017-2018), Duke University, Durham, NC; Rachael L. Fleurence, PhD, National Evaluation System for Health Technology Coordinating Center, Arlington, VA, USA; Zeba M. Khan, PhD, Celgene Corporation, Summit, NJ, USA; and Joe DePinto, Cardinal Health Specialty Solutions. Ms Cooke stressed that diversity is a proven tool to improve business performance—making the advancement of women in leadership not a “women’s issue,” but rather a “business issue.” She noted that working together will help move toward gender parity faster. The panel discussed a variety of issues, including the importance of including men as allies in the effort. Dr Reed spoke about the vision of the new initiative and the importance of advancing women’s leadership in the HEOR field. She presented evidence that consistently demonstrates how organizations with diverse leadership teams perform significantly better than those that lack diversity. Data also show, however, that women account for less than a third (28.4%) of those employed in scientific research and earn less (83%) than men in science, technology, engineering, and mathematics (STEM) fields. During the panel discussion, Dr Reed noted that everyone deserves the opportunity to fully reach their career goals. Dr Khan recommended that women assess the gaps and work to close them by taking calculated risks. Dr Fleurence pointed out that some excellent resources and podcasts on gender parity are available and that women in HEOR should look for opportunities for informal dialog. Mr DePinto stated that every organization should assess its gender parity status start the journey with gender partnerships. Commenting on the Women in HEOR initiative, Dr Reed noted, “We have received an incredible response from the membership and are so excited to see how the Women in HEOR initiative develops to support our female members in STEM. The evidence demonstrates that diverse teams perform much better than those without diversity do. And so this initiative is beneficial not just for ISPOR’s women members, but also for the science and for everyone in the field of HEOR.” Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.

###

ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×